Don’t Forget about Inflammation in AD

Don’t Forget about Inflammation in AD

by | Aug 8, 2022 | Blog

EpicentRx presents data poster at Alzheimer’s Association International Conference (AAIC) Alzheimer’s Disease (AD), the leading worldwide cause of dementia or cognitive decline, continues (and will continue) to perplex the medical community until its main causes are...
EpicentRx Publishes Commentary in International Journal of Infectious Disease (IJID) on Need for a “Universal” Coronavirus Vaccine to be More Effective Against Novel Viral Variants

EpicentRx Publishes Commentary in International Journal of Infectious Disease (IJID) on Need for a “Universal” Coronavirus Vaccine to be More Effective Against Novel Viral Variants

by | Aug 4, 2022 | 2022, Press Releases

Commentary points to need for a vaccine based on nucleocapsid vs. spike protein to make vaccine less vulnerable to mutation and provide stronger immunity to novel viral variants Company’s development of a nucleocapsid vaccine, a recombinant replication-competent...
Spotlight on the Adenovirus of AdAPT-001

Spotlight on the Adenovirus of AdAPT-001

by | Jul 28, 2022 | Blog

Fun fact: “Adenovirus,” a DNA virus, that has been used as a delivery vehicle for spike-based COVID vaccines, is named from the human adenoids, a tonsil-like organ in the back of the nose, where it was first isolated. The purpose of the adenoids is to fight...